Sperling Prostate Center

03/20/2026

Did you know? Examinations have detected prostate cancer in 10% of 50-year-olds, 50% of 60-year-olds and approximately 70% of men over the age of 80.

Increasing use of blood tests to detect prostate cancer is leading to overworked doctors. NTNU has now created an AI diagnostic tool that can help lighten the burden.

03/19/2026

If you have a family history of prostate cancer, don’t panic—but do be watchful so you can catch it early if it develops. That’s when it’s more curable.

Are you worried about getting prostate cancer because of your family history? That’s a pretty good reason to be concerned: not to panic, but to be

03/18/2026

If you’re single, dating, and diagnosed with prostate cancer, when and how do you tell a potential partner you have cancer?

As someone with prostate cancer, you may feel anxious and afraid of dating and sharing details of your condition and treatment. Here are tips for sharing your diagnosis.

03/17/2026

Your PSA test, biopsy and MRI results may show you have low-risk prostate cancer, but may not tell the whole story. Learn how additional tests can reveal more dangerous disease that’s “hiding in plain sight.”

Additional testing of low-risk prostate cancer patients to rule out hidden aggressive disease can boost confidence in choosing a treatment tailored to the patient’s needs.

03/16/2026

🎉 We’re proud to welcome Dr. Eric Walser to the Sperling Prostate Center team. In this narrative profile, learn about his journey from aspiring photojournalist to pioneering interventional radiologist as well as why he’s passionate about advancing prostate cancer care through innovative technologies like focal therapy.

Discover how Dr. Eric Walser combines clinical expertise, patient-centered care, and innovation in prostate health at Sperling Prostate Center.

03/15/2026

A promising new immunotherapy treatment for advanced prostat ecancer has had remarkable results in preliminary clinical trials, offering new hope for patients with metastatic prostate cancer.

Unlike other treatments, the new drug is activated solely within the tumour itself

03/14/2026

Patients on Active Surveillance must do 3 key things: Keep a healthy lifestyle, have regular PSA tests and MRI when advised, and talk with the doctor if considering additional treatments.

A major new review published in BJU International explores additional treatments and lifestyle measures for men with early prostate cancer who are managed with active surveillance, as well as monitoring tools that may help guide care.

03/13/2026

The FDA approved Vybrique™, a form of Vi**ra as a film that dissolves on the tongue without food or water.

Vybrique (sildenafil) is a new form of treatment for erectile dysfunction (ED) in adult men. It’s the first version of sildenafil available in the U.S. as a single-dose oral film that dissolves on your tongue (without needing water or other liquids) and can be taken 30 minutes to four hours before...

03/11/2026

🎉 Sperling Prostate Center is proud to welcome Dr. Eric Walser, former Professor and Chairman of Radiology at the University of Texas and a leading authority in minimally invasive focal therapy for prostate cancer and BPH.

With more than two decades of clinical experience, he has treated hundreds of patients and is widely recognized as a pioneer in focal ablation therapies.

Dr. Walser is also a key developer of MRI-directed ultrasound-guided transperineal focal laser ablation (TPLA), an innovative treatment that will now be offered at Sperling Prostate Center.

We could not be happier to have Dr. Walser join us and bring his expertise to our patients.

Dr. Eric Walser, pioneer in focal prostate cancer ablation and clinical researcher, is now part of Sperling Prostate Center’s medical team.

03/04/2026

🎉 Did you know? Seven in 10 cancer patients now survive 5 years or more after diagnosis, a new watershed reported by the American Cancer Society.

Seven in 10 people now survive five years or more after diagnosis, according to the latest annual report from the American Cancer Society.

03/02/2026

PSA screening prevents more deaths than previously thought, while overdiagnosis – and its associated harms – has fallen. MRI has improved the balance between benefit and harm.

Learn more at: https://www.sciencemediacentre.org/expert-reaction-to-23-year-follow-up-data-from-the-european-randomized-study-of-screening-for-prostate-cancer/

02/28/2026

The US Department of Health and Human Services is considering launching a federal men’s health initiative. WiredRFK Jr.’s Health Department Is Pondering a National Men’s Health Initiative

At an FDA discussion of testosterone replacement therapy, a top official called for special health centers to address a “men’s health crisis.” Others called to ease men’s access to hormones.